Penny Stocks Gaining Investor's Attention - FANNIE MAE PFD S (OTC:FNMAS), Green Innovations Ltd (OTC:GNIN), AccelPath (OTC:ACLP)

New York, NY -- (SBWIRE) -- 03/01/2013 -- StockRunway.com issues special report on trending penny stocks – FANNIE MAE PFD S (OTC:FNMAS), Green Innovations Ltd (OTC:GNIN), AccelPath Inc (OTC:ACLP).

FANNIE MAE PFD S (OTC:FNMAS) is trading with a rise of +1.96% along with the exchange price of $2.08 up till now while its today’s introductory price for today was $2.17.

Company’s 6 month’s performance gave a bright outlook overview as it gained +131.11% while in its last 5 days its performance remained green with an improvement of +4%.

Has FNMAS Found The Bottom And Ready To Gain Momentum? Find Out Here

52 week price range of the company is $0.46 - $2.53 while today till 10:19AM its minimum price was $2.08. FANNIE MAE PFD recently added a volume of 2.19 million shares versus its average volume of 1.84 million shares. Federal National Mortgage Association (Fannie Mae) provides liquidity and stability support in the secondary mortgage market in the United States. The company securitizes mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS).

Green Innovations Ltd (OTC:GNIN)’s shares traded up +11.70% during current trading session, hitting $1.05 recently.

The share price of GNIN is currently trading with-in the range of $0.92 to $1.08. The company has a market capitalization of $105.00 million whereas its total outstanding shares are 100.00 million. Green Innovations’s current trading volume is 3.07 million while its average volume is 2.43 million shares. Green Innovations Ltd. imports and distributes bamboo-based hygienic and household products under the Brand names Premium Formulation, Clearly Herbal, and Green & Soft. The company was formerly known as Green Hygienics, Inc. and changed its name to Green Innovations Ltd. in September, 2012.

For How Long GNIN’s Gloss will Attract Investors? Find out via this report

AccelPath Inc (OTC:ACLP)’s shares traded down -6.67% during current trading session, hitting $0.0014 recently. The company has a market capitalization of $206,929.00 whereas its total outstanding shares are 147.81 million. Company’s beta value stands at -6.67 points.

Why Should Investors Buy ACLP After the Recent Fall? Just Go Here and Find Out

AccelPath’s current trading volume is 1.98 million while its average volume is 4.74 million shares. Last 5 day’s trade of the company showing a negative performance overall, with loosing stream of -30%. In last 6 months it showed performance downturn and lost -85.11%. AccelPath, Inc. provides medical diagnostic and government contracting services in the United States. It engages in the design, research and development, integration, sale, and support of three-dimensional (3D) imaging devices and systems for diagnosis of diseases and other pathologic conditions in the healthcare industries; and intelligent surveillance devices and systems, and 3D facial recognition in the security industries.

About StockRunway.com
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.

Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!

Disclaimer
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.